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INTRODUCTION 
 
Recent evidence supports the contention that cellular 
senescence is associated with, and may even be a cause 
of age-related functional impairment. Senescent cells 
accumulate in multiple tissues with advancing age [1]. 
Cellular senescence causes a variety of cell types to 
acquire a pro-inflammatory secretory phenotype that 
produce a variety of cytokines, chemokines, and 
extracellular matrix remodeling proteases that are 
associated with tissue destruction [2-5]. Chronic 
presence of senescent cells can accelerate cancer 
progression, possibly because of this inflammatory 
secretory phenotype [6-7]. Engineered deposition of 
senescent cells in a single organ, skin, can cause 
functional impairments in multiple organs similar to 
those occurring with aging [8]. Finally, senescent cell 
accumulation in progeroid animal models is associated 
with dysfunction resembling that of aging [9]. Caloric 
restriction attenuates processes that have been 
implicated in cellular senescence, including generation 
of reactive oxygen species (ROS), growth 
hormone/insulin-like growth factor-1 signaling, and 
inflammation [10-12]. 
 
Does caloric restriction in fact reduce cellular 
senescence? In an important study in this journal, Wang 
et al. found short term dietary restriction in middle-aged 
mice is associated with decreased abundance of 
senescent cells in the liver (centrilobular hepatocytes) 
and intestine (crypt enterocytes) [13]. They detected this 
reduction following 3 months of 26% caloric restriction 
in 17 month old mice by assaying cellular γH2AX (a 
protein that associates with damaged DNA), PCNA (an 
indicator of replication),  and  senescence-associated  β- 
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galactosidase (SA β–gal). The relatively short period of 
caloric restriction resulted in a 3.3 to 6.5% decrease in 
senescent cell abundance as a function of total cell 
number. Despite similar or lower telomerase activity in 
the calorically restricted compared to ad libitum-fed 
mice, average telomere length in crypt enterocyte nuclei 
was greater in the calorically restricted animals. The 
telomere preservation could have been a result of 
reduced ROS in the calorically restricted animals, since 
ROS accelerate telomeric DNA loss. Consistent with 
this possibility, the authors found that markers of 
cellular oxidative damage (4-HNE and broad-band 
autofluorescence) were lower in the cell types in which 
senescence was reduced in the calorically restricted 
mice. Additional experiments need to be done to test if 
the association between reduced oxidative damage 
following short term caloric restriction and decreased 
senescence reflects a causal relationship. The authors 
suggest that reduced cellular senescence might be a 
primary effect of caloric restriction. They speculate this 
could be mediated through suppression of signaling 
through mTOR and S6K1, and that this might 
contribute to improved mitochondrial function and 
reduced ROS. These possibilities need to be tested 
directly in future studies. 
 
As with many interesting studies, this study raises many 
more questions than it answers. Several of these 
questions, their potential implications, and suggestions 
for further study follow. 
 
Does short term caloric restriction reduce the 
proportion of senescent cells in other tissues, such as 
fat? Obesity, aging, and other conditions are associated 
with extensive accumulation of senescent cells in fat 
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frequently the most abundant tissue in the body [14-16]. 
Fat tissue becomes inflamed in association with 
senescent cell accumulation, potentially leading to 
clinically important systemic consequences such as 
diabetes and atherosclerosis. Fat tissue is also among 
the first tissues to be affected structurally and 
metabolically by caloric restriction, so determining the 
impact of short term caloric restriction on fat tissue 
cellular senescence is particularly important. It would 
also be interesting to determine the impact of short term 
caloric restriction on cellular senescence in other 
tissues, including the brain. This could be particularly 
instructive in animal models of chronic diseases in 
which cellular senescence appears to play a role, such as 
in animal models of progerias or Alzheimer’s disease. 
 
Does short term caloric restriction also reduce 
abundance of senescent cells and inflammation in 
humans? It may not, since, as the authors point out, 
proliferation-competent skin fibroblasts did not increase 
after 9 to 12 years of caloric restriction in rhesus 
monkeys [17]. On the other hand, it might, since white 
blood cell DNA fragmentation (by comet assay) 
declines in overweight but non-obese adult human 
subjects subjected to 25% caloric restriction for 6 
months [18]. If sufficient baseline cellular senescence is 
in fact evident in ad libitum-fed subjects in accessible 
tissues (for example, subcutaneous fat) from subjects in 
current human trials of short term caloric restriction, it 
may be informative to determine if decreases in cellular 
senescence occur in the calorically restricted subjects. 
 
What is the cell dynamic mechanism that causes 
decreased senescence during short term caloric 
restriction? Altered rates of senescent cell formation or 
removal could be responsible for the effect of short term 
caloric restriction on abundance of senescent cells. 
Senescent cells normally accumulate at a rate of 0.5% 
or less per month as a function of total cell number in 
the tissues examined. Caloric restriction resulted in a 
3.3 to 6.5% decrease in senescent cell abundance as a 
function of total cell number. Since senescent cells 
generally appear to turn over slowly, this implies that 
declines in production of new senescent cells may be 
accompanied by increased removal. Senescent cells can 
be removed through activation of the immune system, 
with the immune system being activated by factors 
released by senescent cells [4]. Short term caloric 
restriction could enhance immune system responsive-
ness to senescent cells, a possibility that remains to be 
tested. Fully established cellular senescence might not 
be easily reversible, further suggesting that short term 
caloric restriction enhances clearance of senescent cells 
by the immune system. Whether caloric restriction 
improves immune recognition and clearance of 
senescent cells is an issue that merits further study. 
 
What is the molecular mechanism behind the decrease 
in senescent cells due to short term caloric restriction? 
This is a key question in determining if there is a path to 
mechanism-based clinical interventions that would 
reduce the low grade tissue inflammation associated 
with many of the diseases common in old age. As the 
authors state, long term caloric restriction reduces 
phosphorylation and activity of Akt1, mTOR, and its 
downstream targets S6K1 and 4E-BP1. Activated S6K1 
binds to Mdm2, inhibiting Mdm2-mediated p53 
ubiquitination, increasing p53 stability, and thereby 
potentially inducing senescence. Whether this sequence 
of events occurs in short term caloric restriction needs 
to be investigated. 
 
It would be very informative to test if rapamycin or 
reducing expression of S6K1 decreases senescent cell 
abundance in centrilobular hepatocyte and intestinal 
crypt enterocyte populations in a manner similar to 
short term caloric restriction. It would also be 
informative to test if expressing activated S6K1 or 
increasing activity of other mTOR pathway components 
blocks the impact of caloric restriction on reducing 
accumulation of senescent cells. Additionally, it would 
be interesting to test if Akt activation, perhaps by IGF-
1, prevents the caloric restriction-related reduction in 
cellular senescence, especially as IGF-1 decreases 
within hours to days after starting food restriction in 
rodents [19-20]. 
 
What are the effects of short compared to long term 
caloric restriction on cellular senescence and 
inflammation? How rapidly does the decline in cellular 
senescence occur and does this vary among tissues? 
Although they might appear incremental, time 
consuming, and expensive, time course studies are 
necessary. These studies could provide some 
mechanistic information, but they will be especially 
valuable when it comes to designing potential 
interventions. 
 
Are effects of short term caloric restriction different in 
old than younger individuals? The burden of senescent 
cells increases in most tissues with aging. If short term 
caloric restriction indeed reduces cellular senescence in 
a variety of tissues, it would appear quite plausible that 
the impact of short term caloric restriction would be 
greater in older than younger individuals. However, 
macrophage induction by the types of chemokines 
released by senescent cells may decline with aging [14, 
21]. If the mechanism of reduced senescent cell 
abundance is related to increased clearance by 
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actually be less effective in very elderly than middle-
aged individuals. This issue will need to be tested 
experimentally. Furthermore, as the authors point out, 
late onset caloric restriction could have beneficial 
effects in humans since even if long term caloric 
restriction is initiated in later life, there are declines in 
cancer incidence and enhancements in cognitive 
function and immune responses. Indeed, the latter could 
account for the senescent cell clearance induced by 
caloric restriction. 
 
Can clinical interventions be developed based on 
reducing cellular senescence and inflammation through 
manipulating the pathways activated by short term 
caloric restriction? This is of course the most important 
question. Depending on the answers to the preceding 
questions, this may be a possibility. Although highly 
speculative, attacking senescent cells or their pro-
inflammatory phenotype could form the basis for 
developing pharmacological interventions that could 
reduce age-related frailty, metabolic and cognitive 
dysfunction, cancers, and other potential consequences 
of widespread tissue inflammation as a group. Before 
pursuing this further, it will be necessary to prove that 
removing senescent cells selectively can restore 
function in old age and delay age-related disease onset. 
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